Leuven Gynaecological Oncology Group

Shaping the future treatments for our patients

I'm looking for clinical trials and I'm a
Caregiver

I'm a caregiver and looking for a clinical trial for my patient

I'm looking for clinical trials and I'm a
Patient

I'm a patient and looking for a clinical trial for myself

We're here to help with your therapy

LGOG, the Leuven Gynaecological Oncology Group, originated from the department of gynaecological oncology at the University Hospital Leuven.

Our department specialises in the diagnosis and treatment of gynaecological cancers. These include cancers of the ovaries, fallopian tubes, peritoneum, uterus, cervix and placenta.

Our team

Message board

Symposium Gynaecologic pelvine oncology: 'From evidence to reality'

On Wednesday November 25th, 2026 the first symposium of Gynaecologic Pelvine Oncology will take place. The goal of this symposium is to gather health care professionals to translate new insights in…

New Study Confirms Beneficial Effect of Relacorilant

An international phase III study conducted by Corcept demonstrates that the combination of relacorilant and nab-paclitaxel results in a statistically significant improvement in progression-free…

Pembrolizumab Improves Disease-Free Survival in dMMR Endometrial Carcinoma

A randomized double-blind phase III study conducted by Merck Sharp & Dohme demonstrates that adding pembrolizumab to first-line chemotherapy does not improve disease-free survival in the overall…

Bekijk alle berichten

Founding Member of

the Belgium and Luxembourg Gynaecologic Oncology Group (BGOG) & the European Network of Gynaecologic Oncological Trial Groups (ENGOT)